ArticleThe Journal of cell biology2010

Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma.

Bernhard Gillissen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.